Tavlesse

Five drugs, including two Novartis therapies, win EMA endorsement
Endpoints
Fri, 11/15/19 - 12:22 pm
EMA
Europe
Novartis
Mayzent
Isturisa
Roche
Polivy
Jazz Pharma
Sunosi
Rigel Pharma
Tavlesse